Bloomberg reporting that:
“Merck & Co. lost a U.S. appeals court bid to revive a patent-infringement claim against generic-drug maker Apotex Inc. over a copy of the allergy medicine Nasonex.”
The full story here:
Bloomberg reporting that:
“Merck & Co. lost a U.S. appeals court bid to revive a patent-infringement claim against generic-drug maker Apotex Inc. over a copy of the allergy medicine Nasonex.”
The full story here: